[HTML][HTML] Butyrylcholinesterase is a potential biomarker for sudden infant death syndrome

CT Harrington, N Al Hafid, KA Waters - EBioMedicine, 2022 - thelancet.com
… pathophysiology of the Sudden Infant Death Syndrome (SIDS). Butyrylcholinesterase (BChE)
is … to evaluate BChE activity in infants and young children who had died from Sudden Infant

Is butyrylcholinesterase a potential biomarker for sudden infant death syndrome's prevention?: a pilot, retrospective, case-control study

B Solé Roqueta - 2023 - dugi-doc.udg.edu
… screening program is associated with sudden infant death syndrome. And the secondary …
PARTICIPANTS: Cases: Infants who died from sudden infant death syndrome in the last five …

[HTML][HTML] Refocusing SIDS research: Is butylcholinesterase a predictive biomarker?

E Matthews - EBioMedicine, 2022 - thelancet.com
… They also include sudden infant death syndrome a term allocated to an infant … A perspective
on neuropathologic findings in victims of the sudden infant death syndrome: the triple-risk …

Letter to Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome

J Durner - Ebiomedicine, 2022 - thelancet.com
… , The article “Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome
was … as to whether the analyte butyrylcholinesterase is already available and why not yet. …

[PDF][PDF] Letter Re: Butyrylcholinesterase is a potential biomarker for sudden infant death syndrome

CT Harrington, N Al Hafid, KA Waters - EBioMedicine, 2022 - thelancet.com
Dear Editor, Prof Durner, Thank you for highlighting the overlap of low BChE levels between
our SIDS and non-SIDS groups as one factor limiting the capacity for this measurement to …

Identification of Decreased Butyrylcholinesterase in Sudden Infant Death Syndrome Is, at Best, a First Step Toward Preventive Screening

PL Hall, D Matern - Clinical Chemistry, 2023 - academic.oup.com
… Harrington et al. recognize the potential for inclusion of SIDS in NBS and recommend urgent
work on this potential biomarker; however, they do not provide an assessment of SIDS in …

[HTML][HTML] … ) and acetylcholinesterase (AChE) in the human infant dorsal motor nucleus of the Vagus (DMNV), and alterations according to sudden infant death syndrome …

M Joda, KA Waters, R Machaalani - Neurobiology of Disease, 2023 - Elsevier
… the reaction (Taylor and Brown, 1999b), Acetylcholinesterase (AChE), the primary hydrolysis
enzyme that rapidly disintegrates ACh after signal transduction, and Butyrylcholinesterase (…

Prenatal nicotine-exposure alters fetal autonomic activity and medullary neurotransmitter receptors: implications for sudden infant death syndrome

JR Duncan, M Garland, MM Myers… - Journal of Applied …, 2009 - journals.physiology.org
… of the sudden infant death syndrome (SIDS) two- to fivefold. Serotonergic (5-HT) abnormalities
are found, in infants … the sudden infant death syndrome (SIDS) is the sudden death of an …

Cholinergic Immunohistochemistry in the Brainstem, Focusing on the Dorsal Motor Nucleus of the Vagus (DMNV), and changes within Sudden Infant Death Syndrome …

M Al Deleemy - 2022 - ses.library.usyd.edu.au
Introduction: A dominating hypothesis of Sudden Infant Death Syndrome (SIDS), which is
defined as the unexpected death, usually during sleep, in seemingly healthy infants under the …

Clinical Pearl: A New Potential Biomarker for Sudden Infant Death Syndrome (SIDS): Butyrylcholinesterase.

JR Hageman - Neonatology Today, 2022 - search.ebscohost.com
… who died at age 12-24 months of age of Sudden Unexplained Death of Infancy (SUDI) (1).
They found significantly lower butyrylcholinesterase levels in the blood of SIDS infants (1).” …